Pfizer has located its corporate headquarters for the Center for Therapeutic Innovation group in the Center for Life Science | Boston (CLSB) building on the top floor, in the heart of the Longwood Medical Area. The strategic decision to develop three Centers for Therapeutic Innovation (CTI), in Boston, New York and San Francisco, is part of a global initiative to foster new collaborations with the city’s major medical centers and institutions (Beth Israel Deaconess Medical Center, Boston University Medical Center, Children’s Hospital Boston, Harvard Medical School, Partners HealthCare, Tufts Medical Center and the University of Massachusetts Medical School). The goal in forging these institutional partnerships is to strengthen research discovery through clinical trial programs that establish proof-of-mechanism in humans more efficiently, to quickly benefit patients in need.
- Modular, open-plan office areas maximize the deep penetration of natural light and offer striking views of Boston.
- Small, glass enclosed ‘touch-down’ rooms and ‘markerboard’ paint in corridors are provided along major circulation paths to encourage impromptu meetings and collaboration. Perforated metal accents and strong linear forms reinforce a modern culture and create way finding cues upon arrival.
- Full height glass doors and an electric glazed operable garage door separate the main conference center from the lobby. These features, combined with a tackable room divider partition, allow for flexible configurations within the space. Such flexibility was considered a key element in relating the function of the limited space to the brand identity of the CTI group.